Open original FDA record ↗Recall record
- FDA identifier
- Z-2134-2021
- Company in FDA record
- Cytocell Ltd.
- FDA record creation date
- Jul 23, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The device may show unexpected locus specific signals in addition to those at 22q. Users may observe faint additional locus specific signals at 20p12/13.
Source facts
- Action
- An Urgent Medical Device Recall notification letter dated 5/17/21 was sent to customers. Actions to be taken by [Customer/User] Immediately examine your inventory and quarantine all product subject to recall. Cytocell requests that you destroy the remaining inventory. We also suggest that laboratories undertake a review any results obtained with the affected devices and check that signal patterns were not misinterpreted as a result of any additional locus specific signal at 20p12/13. Corrective and Preventative Actions: Cytocell are currently investigating how this issue occurred and will be implementing the necessary corrective and preventative actions to reduce the risk of recurrence. Your assistance is appreciated and necessary to ensure the interpretation of a result from a resulting LDT is not affected. Please complete and return the enclosed response form as soon as possible. We wish to sincerely apologise for any inconvenience caused as a result of this medical device recall. If you have any questions, contact Cytocell on Tel: +44 (0)1223 294048, Fax +44(0)1223 294986 or vigilance@ogt.com.
- Initiated
- 2021-05-17
- Root cause
- Nonconforming Material/Component
- Terminated
- 2022-08-15
- Distribution
- Distribution to US states of CA, IL, MO, NY, PA, TX, and UT, and Canada.
- Recall number
- Z-2134-2021
- Recall status
- Terminated
- CDRH record ID
- 187967
- FDA record created
- 2021-07-23
- Recall event number
- 88138